Page last updated: 2024-09-02

5-hydroxydopamine and sotalol

5-hydroxydopamine has been researched along with sotalol in 3 studies

Compound Research Comparison

Studies
(5-hydroxydopamine)
Trials
(5-hydroxydopamine)
Recent Studies (post-2010)
(5-hydroxydopamine)
Studies
(sotalol)
Trials
(sotalol)
Recent Studies (post-2010) (sotalol)
71002,196346291

Protein Interaction Comparison

ProteinTaxonomy5-hydroxydopamine (IC50)sotalol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)3.8169
Beta-1 adrenergic receptorHomo sapiens (human)7.1087
Beta-3 adrenergic receptorHomo sapiens (human)7.2
Beta-2 adrenergic receptorCanis lupus familiaris (dog)5.0667

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadzi, D; Lukovits, I; Solmajer, T1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Glen, RC; Lowe, R; Mitchell, JB1

Other Studies

3 other study(ies) available for 5-hydroxydopamine and sotalol

ArticleYear
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:12

    Topics: Chemical Phenomena; Chemistry, Physical; Electrochemistry; Molecular Conformation; Phenethylamines; Receptors, Adrenergic; Structure-Activity Relationship

1982
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010